Loading stock…

Dolby Laboratories, Inc. (DLB) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

DLBDolby Laboratories

Revenue FY25$1.3B

GROWTH RATING↗

AVERAGE38 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+4%4

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+67%10

EPS growth, FY27E+6%5

EPS growth, FY28E+19%8

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 19%/yr vs revenue 4%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 38% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 2%/yr over the last 3 years and is set to keep growing around 4%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE35 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return+19%9

YTD return-7%4

MID & LONG-TERM▾SCORE

% of 52-week high82%6

1-year return-14%3

3-year return-23%2

5-year return-29%2

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+19%).

WATCH

It's down 14% over the past year, now 18% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-6%) and so far this year (-7%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-23% over three years and -29% over five), behind 80% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Dolby Labs. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

DLBDolby Laboratories

Revenue FY25$1.3B

GROWTH RATING↗

AVERAGE38 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+4%4

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+67%10

EPS growth, FY27E+6%5

EPS growth, FY28E+19%8

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 19%/yr vs revenue 4%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 38% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 2%/yr over the last 3 years and is set to keep growing around 4%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE35 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return+19%9

YTD return-7%4

MID & LONG-TERM▾SCORE

% of 52-week high82%6

1-year return-14%3

3-year return-23%2

5-year return-29%2

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+19%).

WATCH

It's down 14% over the past year, now 18% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-6%) and so far this year (-7%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-23% over three years and -29% over five), behind 80% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Dolby Labs. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Dolby Laboratories, Inc.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Dolby Labs. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Dolby Labs. Get the full investment case.

Premium